BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 18164057)

  • 1. PYY transgenic mice are protected against diet-induced and genetic obesity.
    Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY regulates bone turnover in rodents.
    Wortley KE; Garcia K; Okamoto H; Thabet K; Anderson KD; Shen V; Herman JP; Valenzuela D; Yancopoulos GD; Tschöp MH; Murphy A; Sleeman MW
    Gastroenterology; 2007 Nov; 133(5):1534-43. PubMed ID: 17920065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).
    Challis BG; Coll AP; Yeo GS; Pinnock SB; Dickson SL; Thresher RR; Dixon J; Zahn D; Rochford JJ; White A; Oliver RL; Millington G; Aparicio SA; Colledge WH; Russ AP; Carlton MB; O'Rahilly S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4695-700. PubMed ID: 15070780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset PYY overexpression in mice reduces food intake and increases lipogenic capacity.
    Shi YC; Hämmerle CM; Lee IC; Turner N; Nguyen AD; Riepler SJ; Lin S; Sainsbury A; Herzog H; Zhang L
    Neuropeptides; 2012 Aug; 46(4):173-82. PubMed ID: 22575886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
    Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
    Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
    Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
    Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet.
    Lee M; Kim A; Chua SC; Obici S; Wardlaw SL
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E121-31. PubMed ID: 17374695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of hypothalamic CART mRNA in response to body weight change following different dietary interventions.
    Yu Y; South T; Wang Q; Huang XF
    Neurochem Int; 2008 Jun; 52(8):1422-30. PubMed ID: 18455834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.
    Boey D; Lin S; Karl T; Baldock P; Lee N; Enriquez R; Couzens M; Slack K; Dallmann R; Sainsbury A; Herzog H
    Diabetologia; 2006 Jun; 49(6):1360-70. PubMed ID: 16680491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
    Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
    Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
    van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
    J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.
    Kirchner H; Tong J; Tschöp MH; Pfluger PT
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E909-19. PubMed ID: 20179246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
    Zhang Y; Guo K; LeBlanc RE; Loh D; Schwartz GJ; Yu YH
    Diabetes; 2007 Jun; 56(6):1647-54. PubMed ID: 17360978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity.
    Mori MA; Araújo RC; Reis FC; Sgai DG; Fonseca RG; Barros CC; Merino VF; Passadore M; Barbosa AM; Ferrari B; Carayon P; Castro CH; Shimuta SI; Luz J; Bascands JL; Schanstra JP; Even PC; Oliveira SM; Bader M; Pesquero JB
    Diabetes; 2008 Jun; 57(6):1491-500. PubMed ID: 18332096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet high in oat β-glucan activates the gut-hypothalamic (PYY₃₋₃₆-NPY) axis and increases satiety in diet-induced obesity in mice.
    Huang XF; Yu Y; Beck EJ; South T; Li Y; Batterham MJ; Tapsell LC; Chen J
    Mol Nutr Food Res; 2011 Jul; 55(7):1118-21. PubMed ID: 21688388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.